Cas no 956395-22-5 (1-(3-Fluorobenzyl)-1h-pyrazol-4-amine Dihydrochloride)
1-(3-Fluorobenzyl)-1h-pyrazol-4-amine Dihydrochloride Chemical and Physical Properties
Names and Identifiers
-
- 1-(3-Fluorobenzyl)-1H-pyrazol-4-amine
- 1-(3-Fluoro-benzyl)-1H-pyrazol-4-ylamine
- SCHEMBL3616273
- EN300-228966
- AKOS000205248
- 956395-22-5
- MFCD02253996
- 1-[(3-fluorophenyl)methyl]-1h-pyrazol-4-amine
- 1-[(3-fluorophenyl)methyl]pyrazol-4-amine
- BBL029650
- STK312459
- 1-(3-Fluorobenzyl)-1h-pyrazol-4-amine Dihydrochloride
-
- MDL: MFCD02253996
- Inchi: 1S/C10H10FN3/c11-9-3-1-2-8(4-9)6-14-7-10(12)5-13-14/h1-5,7H,6,12H2
- InChI Key: DNOLCFDXGUQEQK-UHFFFAOYSA-N
- SMILES: FC1=CC=CC(=C1)CN1C=C(C=N1)N
Computed Properties
- Exact Mass: 191.08587549g/mol
- Monoisotopic Mass: 191.08587549g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 14
- Rotatable Bond Count: 2
- Complexity: 188
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 1.2
- Topological Polar Surface Area: 43.8?2
Experimental Properties
- Density: 1.3±0.1 g/cm3
- Boiling Point: 365.3±27.0 °C at 760 mmHg
- Flash Point: 174.7±23.7 °C
- Vapor Pressure: 0.0±0.8 mmHg at 25°C
1-(3-Fluorobenzyl)-1h-pyrazol-4-amine Dihydrochloride Security Information
- Signal Word:warning
- Hazard Statement: H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
- Warning Statement: P264+P280+P305+P351+P338+P337+P313
- Safety Instruction: H303+H313+H333
- Storage Condition:storage at -4℃ (1-2weeks), longer storage period at -20℃ (1-2years)
1-(3-Fluorobenzyl)-1h-pyrazol-4-amine Dihydrochloride Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | F870220-100mg |
1-(3-Fluorobenzyl)-1h-pyrazol-4-amine Dihydrochloride |
956395-22-5 | 100mg |
$ 70.00 | 2022-06-04 | ||
| TRC | F870220-500mg |
1-(3-Fluorobenzyl)-1h-pyrazol-4-amine Dihydrochloride |
956395-22-5 | 500mg |
$ 230.00 | 2022-06-04 | ||
| TRC | F870220-1g |
1-(3-Fluorobenzyl)-1h-pyrazol-4-amine Dihydrochloride |
956395-22-5 | 1g |
$ 340.00 | 2022-06-04 | ||
| Chemenu | CM274427-1g |
1-(3-Fluorobenzyl)-1H-pyrazol-4-amine |
956395-22-5 | 95+% | 1g |
$479 | 2021-08-18 | |
| Fluorochem | 030147-1g |
1-(3-Fluoro-benzyl)-1H-pyrazol-4-ylamine |
956395-22-5 | 95% | 1g |
£96.00 | 2022-03-01 | |
| Fluorochem | 030147-5g |
1-(3-Fluoro-benzyl)-1H-pyrazol-4-ylamine |
956395-22-5 | 95% | 5g |
£287.00 | 2022-03-01 | |
| Chemenu | CM274427-1g |
1-(3-Fluorobenzyl)-1H-pyrazol-4-amine |
956395-22-5 | 95%+ | 1g |
$359 | 2024-07-18 | |
| Enamine | EN300-228966-0.05g |
1-[(3-fluorophenyl)methyl]-1H-pyrazol-4-amine |
956395-22-5 | 95% | 0.05g |
$24.0 | 2024-06-20 | |
| Enamine | EN300-228966-0.1g |
1-[(3-fluorophenyl)methyl]-1H-pyrazol-4-amine |
956395-22-5 | 95% | 0.1g |
$36.0 | 2024-06-20 | |
| Enamine | EN300-228966-0.25g |
1-[(3-fluorophenyl)methyl]-1H-pyrazol-4-amine |
956395-22-5 | 95% | 0.25g |
$51.0 | 2024-06-20 |
1-(3-Fluorobenzyl)-1h-pyrazol-4-amine Dihydrochloride Related Literature
-
Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
-
Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
-
Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
-
Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
-
Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
Additional information on 1-(3-Fluorobenzyl)-1h-pyrazol-4-amine Dihydrochloride
1-(3-Fluorobenzyl)-1h-pyrazol-4-amine Dihydrochloride (CAS No. 956395-22-5): A Comprehensive Overview
1-(3-Fluorobenzyl)-1h-pyrazol-4-amine Dihydrochloride (CAS No. 956395-22-5) is a specialized chemical compound that has garnered significant attention in pharmaceutical and biochemical research. This compound, characterized by its unique molecular structure, plays a pivotal role in the development of novel therapeutic agents. Its fluorobenzyl and pyrazole moieties make it a valuable intermediate in medicinal chemistry, particularly in the design of targeted drug molecules.
The growing interest in 1-(3-Fluorobenzyl)-1h-pyrazol-4-amine Dihydrochloride is driven by its potential applications in addressing contemporary health challenges. Researchers are increasingly exploring its utility in the development of treatments for neurological disorders and inflammatory conditions, which are among the most searched topics in medical and biochemical forums today. The compound's ability to modulate specific biological pathways makes it a promising candidate for next-generation therapeutics.
From a structural perspective, 1-(3-Fluorobenzyl)-1h-pyrazol-4-amine Dihydrochloride features a pyrazole ring substituted with a 3-fluorobenzyl group and an amine functionality. This configuration enhances its reactivity and binding affinity, making it suitable for various synthetic applications. The dihydrochloride salt form improves its solubility and stability, which are critical factors in pharmaceutical formulations.
In the realm of drug discovery, 1-(3-Fluorobenzyl)-1h-pyrazol-4-amine Dihydrochloride is often utilized as a building block for more complex molecules. Its incorporation into drug candidates has shown promising results in preclinical studies, particularly in targeting enzymes and receptors associated with chronic diseases. This aligns with the current trend in pharmaceutical research, where there is a high demand for compounds that can address unmet medical needs.
The synthesis of 1-(3-Fluorobenzyl)-1h-pyrazol-4-amine Dihydrochloride involves multi-step organic reactions, ensuring high purity and yield. Advanced analytical techniques, such as NMR and HPLC, are employed to verify its chemical identity and quality. These rigorous protocols ensure that the compound meets the stringent standards required for research and development purposes.
Market dynamics indicate a rising demand for 1-(3-Fluorobenzyl)-1h-pyrazol-4-amine Dihydrochloride, driven by the expanding pharmaceutical and biotechnology sectors. Companies specializing in fine chemicals and custom synthesis are increasingly offering this compound to meet the needs of academic and industrial researchers. Its versatility and potential for innovation make it a sought-after material in the scientific community.
In conclusion, 1-(3-Fluorobenzyl)-1h-pyrazol-4-amine Dihydrochloride (CAS No. 956395-22-5) represents a critical component in modern chemical and pharmaceutical research. Its unique properties and broad applicability position it as a key player in the development of new therapeutic solutions. As research continues to uncover its full potential, this compound is expected to remain at the forefront of scientific and medical advancements.
956395-22-5 (1-(3-Fluorobenzyl)-1h-pyrazol-4-amine Dihydrochloride) Related Products
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)